574 related articles for article (PubMed ID: 29054493)
1. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
[TBL] [Abstract][Full Text] [Related]
2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
3. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
Fink PB; Deyo RA; Hallvik SE; Hildebran C
Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
[TBL] [Abstract][Full Text] [Related]
4. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
[TBL] [Abstract][Full Text] [Related]
5. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
[TBL] [Abstract][Full Text] [Related]
6. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System.
Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW
J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835
[TBL] [Abstract][Full Text] [Related]
7. Opioid-Prescribing Continuity and Risky Opioid Prescriptions.
Hallvik SE; Geissert P; Wakeland W; Hildebran C; Carson J; O'Kane N; Deyo RA
Ann Fam Med; 2018 Sep; 16(5):440-442. PubMed ID: 30201641
[TBL] [Abstract][Full Text] [Related]
8. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
9. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
[TBL] [Abstract][Full Text] [Related]
10. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
[TBL] [Abstract][Full Text] [Related]
11. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
[TBL] [Abstract][Full Text] [Related]
12. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
[TBL] [Abstract][Full Text] [Related]
13. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
14. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
Brown WC; Whitted K
J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
[TBL] [Abstract][Full Text] [Related]
15. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
16. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
Martello J; Cassidy B; Mitchell A
J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
[TBL] [Abstract][Full Text] [Related]
17. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
[TBL] [Abstract][Full Text] [Related]
18. Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group.
Young LD; Kreiner PW; Panas L
Pain Med; 2018 Jul; 19(7):1396-1407. PubMed ID: 28383713
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
[TBL] [Abstract][Full Text] [Related]
20. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children.
Theodorou CM; Jackson JE; Rajasekar G; Nuño M; Yamashiro KJ; Farmer DL; Hirose S; Brown EG
Pediatr Surg Int; 2021 May; 37(5):659-665. PubMed ID: 33433663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
